Aspirin for Primary Prevention—Time to Rethink Our Approach

Abstract

Over the past decades, the medical community has witnessed a significant improvement in cardiovascular disease (CVD) outcomes. Nonetheless, CVD remains a leading cause of morbidity and mortality globally. Prevention strategies must address all aspects of a patient's lifestyle habits, including healthy nutrition, physical activity, smoking cessation, and stress reduction. 1 When an individual's risk is sufficiently high, pharmacologic therapy is often considered to reduce CVD risk as part of a shared decision-making process for optimal CVD prevention.

Topics & Concepts